Menovo Pharma: Seizing China’s Cell‑Gene Therapy Surge With Strategic API Growth
Explore how Ningbo Menovo Pharmaceutical leverages China’s new fast‑track cell‑ and gene‑therapy policies to grow its high‑purity API business and boost long‑term investor value.
4 minutes to read